While Covid has made many aspects of living with a rare disease more difficult, it has inspired policies and techniques that could help rare disease research progress more smoothly both during and after the pandemic.
Twenty years after researchers published their first discoveries associated with human genome sequencing, policymakers are fighting to overcome obstacles that hobble the potential of genetic medicine to recognize, diagnose and cure rare diseases.
While Covid has made living with rare disease harder than ever, it has also broken down some previously intractable cultural norms in the life sciences. Advocates hope those changes stick so they can find long-overdue cures.
To read the full article, click here.